Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines

Cell Research

Volumn 14, Issue 1, 2004, Pages 67-73

  Sun, Rui ^a,b   Li, Ai Ling ^b   Wei, Hai Ming ^a   Tian, Zhi Gang ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Interleukin 15; Interleukin 2; NK cell; Prolactin receptor

Indexed keywords

MURINAE;

FAS LIGAND; FASLG PROTEIN, HUMAN; GAMMA INTERFERON; IL15RA PROTEIN, HUMAN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MEMBRANE PROTEIN; PERFORIN; PORE FORMING CYTOTOXIC PROTEIN; PROLACTIN; PROLACTIN RECEPTOR; RNA;

ARTICLE; CELL DIVISION; CHEMISTRY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; NATURAL KILLER CELL; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CELL DIVISION; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; PORE FORMING CYTOTOXIC PROTEINS; PROLACTIN; RECEPTORS, INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-2; RECEPTORS, PROLACTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 12344297552     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7290204     Document Type: Article

References (28)

1. Matera L. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 1996; 59:599-614.
2. Murphy WJ, Rui Hallgeir, Longo DL. Effects of growth hormone and prolactin: Immune development and function. Life Sci 1995; 57:1-14.
3. Chikanza IC. Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann N Y Acad Sci 1999; 876:119-30.
4. SM Richards, WJ Murphy. Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function. J Neuroimmunol 2000; 109:56-62.
5. Gala RR, Shevach EM. Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse. Endocrinology 1993; 133:1617-23.
6. Gagnerault MC, Touraine P, Savino W, Kelly PA, Dardenne M. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 1993; 150:5673-81.
7. Prystowsky MB, Clevenger CV. Prolactin as a second messenger for interleukin 2. Immunomethods 1994; 5:49-55.
8. Carlo R Di, Bole-Feysot C, Gualillo O, Meli R, Nagano M, PA Kelly. Regulation of prolactin receptor mRNA expression in peripheral lymphocytes in rats in response to changes in serum concentrations of prolactin. Endocrinology 1995; 136:4713-6.
9. Matera L, Geuna M, Pastore C, Buttiglieri S, Gaidano G, Savarino A, Marengo S, Vonderhaar BK. Expression of prolactin and prolactin receptors by non-Hodgkin's lymphoma cells. Int J Cancer 2000; 85:124-30.
10. Gunes H, Mastro AM. Prolactin receptor gene expression in rat splenocytes and thymocytes during oestrous cycle, pregnancy and lactation. Cell Prolif 1997; 30:219-35.
11. Dardenne M, Moraes M do C de, Kelly PA, Gagnerault MC. Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry. Endocrinology 1994; 34: 2108-14.
12. Neidhart M. Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion. Biomed Pharmacother 1997; 51:118-25.
13. Vidaller A, Guadarrama F, Llorente L, Mendez JB, Larrea F, Villa AR, Alarcon-Segovia D. Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient. J Clin Immunol 1992; 12:210-5.
14. WJ Murphy, SK Durum, MR Anver, DL Longo. Immunological and haematological effects of neuroendocrine hormone: Studies on DW/J dwarf mice. J Immunol 1992; 148:3799-808.
15. P Morales, MV Carretero, H Geronimo, SG Copin, ML Gaspar, MA Marcos, J Martin-Perez. Influence of prolactin on the differentiation of mouse B-lymphoid precursors. Cell Growth Differ1999; 10:583-90.
16. B Bouchard, CJ Ormandy, JP Di Santo, PA Kelly. Immune system development and function in prolactin receptor-deficient mice. J Immunol1999; 163:576-82.
17. Chambers WH, Amoscato AA, Smith MS, Kenniston TW, Herberman RB, Appasamy PM. Prolactin receptor expression by rat NK cells. Nat Immun 1995; 14:145-56.
18. Matera L, Contarini M, Bellone G, Forno B, Biglino A. Up-modulation of interferon-gamma mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells. Immunology 1999; 98:386-92.
19. Oberholtzer E, Contarini M, Veglia F, Cossarizza A, Franceschi C, Geuna M. Prolactin increases the susceptibility of primary leukemia cells to NK and LAK effectors. Adv Neuroimmunol 1996; 6:233-47.
20. Cesano A, Oberholtzer E, Contarini M, Geuna M, Bellone G, Matera L. Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors. Immunopharmacology 1994; 28:67-75.
21. Tian ZG, Woody MA, Sun R, Welniak LA, Raziuddin A, Funakoshi S, et al. Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice. Stem Cells 1998; 16:193-9.
22. Woody MA, Welniak LA, Sun R, Tian ZG, Henry M, Richards S, et al. Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine. Exp Hematol 1999; 27:811-6.
23. Woody MA, Welniak LA, Richards S, Taub DD, Tian D, Sun R, et al. Use of neuroendocrine hormones to promote reconstitution after bone marrow transplantation. Neuroimmunomodulation 1999; 6:69-80.
24. Welniak LA, Tian ZG, Sun R, Keller JR, Richards S, Ruscetti FW, et al. Effects of growth hormone and prolactin on hematopoiesis. Leuk Lymphoma 2000; 38:435-45.
25. Sun R, Wei HM, Zhang JH, Li AL, Zhang WC, Tian ZG. Recombinant Human Prolactin Improves Anti-tumor Effects of Murine NK cells in vitro and in vivo. Neuroimmunomodulation. 2002; 10:169-76.
26. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia1994; 8:652-8.
27. Nagashima S, Mailliard R, Kashii Y, Reichert TE, Herberman RB, Robbins R, et al. Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo. Blood 1998; 91: 3850-61.
28. Tian ZG, Shen X, Feng F, Gao B, IL-1β attenuates IFNβ-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway. J Immunol 2000; 165:3959-66.